PHASE II STUDY OF IRINOTECAN AND OXALIPLATIN (IROX) COMBINATION AS A FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER

ANNALS OF ONCOLOGY(2008)

Cited 0|Views12
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined